top of page
Archive

Δημοσιεύσεις Φοιτητών

Τάξη 2017 — 2019 (72 άρθρα)

  1. AKRIOTI Elissavet - Kalliopi (PAPANIKOLAOU Eleni) doi: 10.1186/s12917-019-2179-z BMC Vet Res. 2019 Nov
    Development of a CRISPR/Cas9 system against ruminant animal brucellosis
     

  2. ​AKRIOTI Elissavet - Kalliopi (TAOUFIK Era) doi: 10.3390/biom12070876 Biomolecules. 2022 Jun
    Early Signs of Molecular Defects in iPSC-Derived Neural Stems Cells from Patients with Familial Parkinson's Disease
    ​

  3. ​ANGELOPOULOU Andriani (GORGOULIS Vassilis G.) doi: 10.3390/cells11152449 Cells. 2022 Aug
    Interplay of Developmental Hippo-Notch Signaling Pathways with the DNA Damage Response in Prostate Cancer
     

  4. ​ANGELOPOULOU Andriani (GORGOULIS Vassilis G.) doi: 10.1002/jbt.23099 J Biochem Mol Toxicol. 2022 Aug
    Low concentrations of bisphenol A promote the activation of the mitochondrial apoptotic pathway on Beta-TC-6 cells via the generation of intracellular reactive oxygen species and mitochondrial superoxide
     

  5. ​ANGELOPOULOU Andriani (GORGOULIS Vassilis G.) doi: 10.1016/j.xpro.2022.101257 STAR Protoc. 2022 Mar
    CRISPR-Cas9-mediated induction of large chromosomal inversions in human bronchial epithelial cells
     

  6. ​ANGELOPOULOU Andriani (GORGOULIS Vassilis G.) doi: 10.15252/embr.202051287 EMBO Rep. 2022 Feb
    RASSF1A disrupts the NOTCH signaling axis via SNURF/RNF4-mediated ubiquitination of HES1  
     

  7. ​ANGELOPOULOU Andriani (GORGOULIS Vassilis G.) doi: 10.1016/j.molcel.2021.10.017 Mol Cell. 2021 Dec
    A recurrent chromosomal inversion suffices for driving escape from oncogene-induced senescence via subTAD reorganization 
     

  8. ​ANGELOPOULOU Andriani (GORGOULIS Vassilis G.) doi: 10.3390/cells10061506 Cells. 2021 Jun
    Regulatory and Functional Involvement of Long Non-Coding RNAs in DNA Double-Strand Break Repair Mechanisms
     

  9. ​ANGELOPOULOU Andriani (GORGOULIS Vassilis G.) doi: 10.3390/biom11010086 Biomolecules. 2021 Jan
    Non-Canonical Functions of the ARF Tumor Suppressor in Development and Tumorigenesis
     

  10. ANGELOPOULOU Andriani (GORGOULIS Vassilis G.) doi: 10.1016/j.pharmthera.2020.107795 Pharmacol Ther. 2021 Jun

    Nanomedicine: Photo-activated nanostructured titanium dioxide, as a promising anticancer agent 
     

  11. ​BONIS Vangelis (KLINAKIS Apostolos) doi: 10.1039/d1sc04465f Chem Sci. 2021 Oct

    The effect of S427F mutation on RXRα activity depends on its dimeric partner
     

  12. BONIS Vangelis (KLINAKIS Apostolos) doi: 10.1172/jci.insight.133232 JCI Insight. 2020 Feb

    Notch controls urothelial integrity in the mouse bladder
     

  13. FANIDIS Dionysios (AIDINIS Vassilis) doi: 10.1038/s41467-026-68377-5 Nat Commun. 2026 Jan

    Versican expression from lung fibroblasts suppresses pulmonary fibrosis
     

  14. FANIDIS Dionysios (AIDINIS Vassilis) doi: 10.3389/fmed.2023.1195501 Front Med (Lausanne). 2023 Sep

    Increased lipocalin-2 expression in pulmonary inflammation and fibrosis
     

  15. FANIDIS Dionysios (AIDINIS Vassilis) doi: 10.1038/s41467-023-41614-x Nat Commun. 2023 Sep

    SRC and TKS5 mediated podosome formation in fibroblasts promotes extracellular matrix invasion and pulmonary fibrosis
     

  16. FANIDIS Dionysios (AIDINIS Vassilis) doi: 10.1016/j.csbj.2023.03.043 Comput Struct Biotechnol J. 2023 Mar

    An explainable machine learning-driven proposal of pulmonary fibrosis biomarkers
     

  17. FANIDIS Dionysios (AIDINIS Vassilis) doi: 10.3390/ijms23137452 Int J Mol Sci. 2022 Jul

    Lysophosphatidic Acid Is a Proinflammatory Stimulus of Renal Tubular Epithelial Cells
     

  18. FANIDIS Dionysios (AIDINIS Vassilis) doi: 10.3390/ijms23073717 Int J Mol Sci. 2022 Mar

    ENPP2 Promoter Methylation Correlates with Decreased Gene Expression in Breast Cancer: Implementation as a Liquid Biopsy Biomarker
     

  19. FANIDIS Dionysios (AIDINIS Vassilis) doi: 10.3390/biomedicines10020494 Biomedicines. 2022 Feb

    Obesity Reshapes the Microbial Population Structure along the Gut-Liver-Lung Axis in Mice
     

  20. FANIDIS Dionysios (AIDINIS Vassilis) doi: 10.3389/fimmu.2021.645548 Front Immunol. 2021 Nov
    Collagen 1a1 Expression by Airway Macrophages Increases In Fibrotic ILDs and Is Associated With FVC Decline and Increased Mortality
     

  21. FANIDIS Dionysios (AIDINIS Vassilis) doi: 10.3390/ijms222111958 Int J Mol Sci. 2021 Nov

    ENPP2 Methylation in Health and Cancer
     

  22. FANIDIS Dionysios (AIDINIS Vassilis) doi: 10.1038/s41598-021-01069-w Sci Rep. 2021 Nov

    Fibromine is a multi-omics database and mining tool for target discovery in pulmonary fibrosis
     

  23. FANIDIS Dionysios (AIDINIS Vassilis) doi: 10.3390/ijms221810006 Int J Mol Sci. 2021 Sep

    Increased Autotaxin Levels in Severe COVID-19, Correlating with IL-6 Levels, Endothelial Dysfunction Biomarkers, and Impaired Functions of Dendritic Cell
     

  24. FANIDIS Dionysios (AIDINIS Vassilis) doi: 10.4049/jimmunol.2000862 J Immunol. 2021 Feb

    MAP3K8 Regulates Cox-2-Mediated Prostaglandin E2 Production in the Lung and Suppresses Pulmonary Inflammation and Fibrosis
     

  25. FANIDIS Dionysios (MOULOS Panagiotis) doi: 10.1093/bib/bbaa156 Brief Bioinform. 2021 May

    Integrative, normalization-insusceptible statistical analysis of RNA-Seq data, with improved differential expression and unbiased downstream functional analysis
     

  26. GARANTZIOTIS Panagiotis (BOUMPAS Dimitrios T.) doi: 10.1136/ard-2023-224919 Ann Rheum Dis. 2024 Mar

    Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression
     

  27. GARANTZIOTIS Panagiotis (BOUMPAS Dimitrios T.) doi: 10.1186/s12864-023-09275-8 BMC Genomics. 2023 Apr

    Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy
     

  28. GARANTZIOTIS Panagiotis (BOUMPAS Dimitrios T.) doi: 10.3389/fimmu.2023.1072598 Front Immunol. 2023 Mar

    The genomic landscape of ANCA-associated vasculitis: Distinct transcriptional signatures, molecular endotypes and comparison with systemic lupus erythematosus
     

  29. GARANTZIOTIS Panagiotis (FRANGOU Eleni) doi: 10.1016/j.autrev.2023.103327 Autoimmun Rev. 2023 Jun

    Glomerulonephritis and inflammatory bowel disease: A tale of gut-kidney axis dysfunction
     

  30. GARANTZIOTIS Panagiotis (BOUMPAS Dimitrios T.) doi: 10.1177/09612033221144425 Lupus. 2023 Feb

    Relapses are common in severe hematologic systemic lupus erythematosus and may be prevented by early institution of immunosuppressive agents: Α real-life single-center study
     

  31. GARANTZIOTIS Panagiotis (BOUMPAS Dimitrios T.) doi: 10.1136/annrheumdis-2021-222069 Ann Rheum Dis. 2022 Oct

    Cross-species transcriptome analysis for early detection and specific therapeutic targeting of human lupus nephritis
     

  32. GARANTZIOTIS Panagiotis (BOUMPAS Dimitrios T.) doi: 10.3389/fneur.2022.889613 Front Neurol. 2022 May

    Demyelinating Syndromes in Systemic Lupus Erythematosus: Data From the "Attikon" Lupus Cohort 
     

  33. GARANTZIOTIS Panagiotis (BOUMPAS Dimitrios T.) doi: 10.3389/fimmu.2022.860726 Front Immunol. 2022 May

    Molecular Taxonomy of Systemic Lupus Erythematosus Through Data-Driven Patient Stratification: Molecular Endotypes and Cluster-Tailored Drugs
     

  34. GARANTZIOTIS Panagiotis (BOUMPAS Dimitrios T.) doi: 10.1016/j.autrev.2021.102949 Autoimmun Rev. 2021 Nov

    Unraveling the complexities of psoriatic arthritis by the use of -Omics and their relevance for clinical care
     

  35. GARANTZIOTIS Panagiotis (BOUMPAS Dimitrios T.) doi: 10.1093/rheumatology/keaa902 Rheumatology (Oxford). 2021 Sep

    Demyelination with autoimmune features: a distinct clinical entity? Results from a longitudinal cohort 
     

  36. GARANTZIOTIS Panagiotis (MAVRAGANI Clio P.) doi: 10.3389/fimmu.2021.683623 Front Immunol. 2021 Jun

    Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren's Syndrome-Related Lymphoma?
     

  37. GARANTZIOTIS Panagiotis (FRANGOU Eleni) doi: 10.3390/jcm10112262 J Clin Med. 2021 May

    Gene Expression as a Guide to the Development of Novel Therapies in Primary Glomerular Diseases
     

  38. GARANTZIOTIS Panagiotis (BERTSIAS George) doi: 10.3390/jcm10050998 J Clin Med. 2021 Mar

    High Comorbidity Burden in Patients with SLE: Data from the Community-Based Lupus Registry of Crete
     

  39. GARANTZIOTIS Panagiotis (BOUMPAS Dimitrios T.) doi: 10.31138/mjr.31.3.366 Mediterr J Rheumatol. 2020 Jul

    Mitophagy Balance in Various Cell Subsets in Patients with ANCA-Associated Vasculitis and Correlation with the Presence of Anti-Neutrophil Cytoplasmic Antibodies
     

  40. GOURLIA Krystallia (AGELAKI Sofia) doi: 10.1371/journal.pone.0252537 PLoS One. 2021 Jun

    Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study
     

  41. KARDALA Eleni (GORGOULIS Vassilis G.) doi: 10.1016/j.celrep.2019.11.017 Cell Rep. 2019 Dec
    A Deep Learning Framework for Predicting Response to Therapy in Cancer
     

  42. KORONAIOU Effrosyni (STEFANIS Leonidas) doi: 10.1016/j.nbd.2022.105612 Neurobiol Dis. 2022 Feb

    A double-hit in vivo model of GBA viral microRNA-mediated downregulation and human alpha-synuclein overexpression demonstrates nigrostriatal degeneration 
     

  43. KORONAIOU Effrosyni (STEFANIS Leonidas) doi: 10.1002/mds.28383 Mov Disord. 2021 Mar

    Psychosis-Like Behavior and Hyperdopaminergic Dysregulation in Human α-Synuclein BAC Transgenic Rats
     

  44. LEGAKI Aigli-Ioanna (CHATZIGEORGIOU Antonios) doi: 10.1016/j.metabol.2025.156325 Metabolism. 2025 Sep
    Exercise mitigates liver senescence but does not outmatch dietary restriction in obesity-related MASLD
     

  45. LEGAKI Aigli-Ioanna (CHATZIGEORGIOU Antonios) doi: 10.1055/a-2437-6308 Thromb Haemost. 2024 Oct

    Association of circulating Robo4 with obesity, hypertension and atherosclerotic plaque burden
     

  46. LEGAKI Aigli-Ioanna (VERGINIS Panayotis) doi: 10.1038/s41467-024-49282-1 Nat Commun. 2024 Jun

    Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development
     

  47. LEGAKI Aigli-Ioanna (CHATZIGEORGIOU Antonios) doi: 10.1007/s00018-023-04966-7 Cell Mol Life Sci. 2023 Oct

    Liver endothelial cells in NAFLD and transition to NASH and HCC
     

  48. LEGAKI Aigli-Ioanna (CHATZIGEORGIOU Antonios) doi: 10.1016/j.metabol.2023.155552 Metabolism. 2023 Jul

    Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity
     

  49. LEGAKI Aigli-Ioanna (CHATZIGEORGIOU Antonios) doi: 10.3791/64838 J Vis Exp. 2023 Mar

    Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
     

  50. LEGAKI Aigli-Ioanna (CHATZIGEORGIOU Antonios) doi: 10.3390/pathogens12030394 Pathogens. 2023 Mar
    Significance of Circulating Cell-Free DNA Biomarkers in HBeAg-Negative Chronic Hepatitis B Virus Infection and Their Changes after Treatment Initiation
     

  51. LEGAKI Aigli-Ioanna (CHATZIGEORGIOU Antonios) doi: 10.3390/ijms24054813 Int J Mol Sci. 2023 Mar

    Analysis of the Role of Stellate Cell VCAM-1 in NASH Models in Mice
     

  52. LEGAKI Aigli-Ioanna (CHATZIGEORGIOU Antonios) doi: 10.1186/s12967-023-03935-9 J Transl Med. 2023 Mar

    Short term starvation potentiates the efficacy of chemotherapy in triple negative breast cancer via metabolic reprogramming
     

  53. LEGAKI Aigli-Ioanna (CHATZIGEORGIOU Antonios) doi: 10.1007/s13679-022-00473-1 Curr Obes Rep. 2022 Sep

    Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease
     

  54. LEGAKI Aigli-Ioanna (CHATZIGEORGIOU Antonios) doi: 10.3389/fcvm.2021.738764 Front Cardiovasc Med. 2021 Oct

    PCSK9/LDLR System and Rheumatoid Arthritis-Related Atherosclerosis
     

  55. LEGAKI Aigli-Ioanna (CHATZIGEORGIOU Antonios) doi: 10.3390/ijms22073446 Int J Mol Sci. 2021 Mar

    Hepatic Senescence Accompanies the Development of NAFLD in Non-Aged Mice Independently of Obesity
     

  56. LEGAKI Aigli-Ioanna (CHATZIGEORGIOU Antonios) doi: 10.1055/s-0040-1714371 Thromb Haemost. 2020 Nov

    Increased Neutrophil Extracellular Traps Related to Smoking Intensity and Subclinical Atherosclerosis in Patients with Type 2 Diabetes
     

  57. LEGAKI Aigli-Ioanna (VERGINIS Panayotis) doi: 10.1016/j.jaut.2019.102310 J Autoimmun. 2019 Nov

    Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells
     

  58. NIKOLAKIS Dimitrios (BOUMPAS Dimitrios T.) doi: 10.1186/s12864-023-09275-8 BMC Genomics. 2023 Apr

    Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy
     

  59. NIKOLAKIS Dimitrios (BOUMPAS Dimitrios T.) doi: 10.3389/fimmu.2023.1072598 Front Immunol. 2023 Mar

    The genomic landscape of ANCA-associated vasculitis: Distinct transcriptional signatures, molecular endotypes and comparison with systemic lupus erythematosus
     

  60. NIKOLAKIS Dimitrios (BOUMPAS Dimitrios T.) doi: 10.3389/fimmu.2022.860726 Front Immunol. 2022 May
    Molecular Taxonomy of Systemic Lupus Erythematosus Through Data-Driven Patient Stratification: Molecular Endotypes and Cluster-Tailored Drugs
     

  61. NTAVELOU Panagiota (KLINAKIS Apostolos) doi: 10.1126/sciadv.abc3099 Sci Adv. 2020 Nov

    The structure-function relationship of oncogenic LMTK3
     

  62. STYLIANAKI Elli-Anna (AIDINIS Vassilis) doi: 10.1016/j.xpro.2025.103721 STAR Protoc. 2025 Jun

    Amplex red assay, a standardized in vitro protocol to quantify the efficacy of autotaxin inhibitors
     

  63. STYLIANAKI Elli-Anna (AIDINIS Vassilis) doi: 10.1016/j.bmcl.2024.129690 Bioorg Med Chem Lett. 2024 May

    Identification of two novel chemical classes of Autotaxin (ATX) inhibitors using Enalos Asclepios KNIME nodes
     

  64. STYLIANAKI Elli-Anna (AIDINIS Vassilis) doi: 10.1016/j.bbamcr.2023.119602 Biochim Biophys Acta Mol Cell Res. 2024 Jan

    L-Dopa decarboxylase modulates autophagy in hepatocytes and is implicated in dengue virus-caused inhibition of autophagy completion
     

  65. STYLIANAKI Elli-Anna (AIDINIS Vassilis) doi: 10.1016/j.ejmech.2023.115130 Eur J Med Chem. 2023 Mar

    "Hit" to lead optimization and chemoinformatic studies for a new series of Autotaxin inhibitors
     

  66. STYLIANAKI Elli-Anna (AIDINIS Vassilis) doi: 10.3390/biomedicines10020494 Biomedicines.2022 Feb

    Obesity Reshapes the Microbial Population Structure along the Gut-Liver-Lung Axis in Mice
     

  67. STYLIANAKI Elli-Anna (AIDINIS Vassilis) doi: 10.3389/fimmu.2021.687397 Front Immunol.2021 Oct

    Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target 
     

  68. STYLIANAKI Elli-Anna (AIDINIS Vassilis) doi: 10.3390/ijms21197002 Int J Mol Sci. 2020 Sep

    Structure-Based Discovery of Novel Chemical Classes of Autotaxin Inhibitors
     

  69. STYLIANAKI Elli-Anna (AIDINIS Vassilis) doi: 10.1016/j.jaut.2019.102327 J Autoimmun. 2019 Nov

    Autotaxin and chronic inflammatory diseases
     

  70. VARVERI Athina (VERGINIS Panayotis) doi: 10.1038/s41467-024-49282-1 Nat Commun. 2024 Jun

    Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development
     

  71. VARVERI Athina (VERGINIS Panayotis) doi: 10.3389/fimmu.2021.731947 Front Immunol. 2021 Sep

    Regulatory T Cells in Autoimmunity and Cancer: A Duplicitous Lifestyle 
     

  72. VARVERI Athina (VERGINIS Panayotis) doi: 10.1016/j.jaut.2019.102310 J Autoimmun. 2019 Nov

    Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells

     

bottom of page